Genmab shifts to innovation-led growth with 21% revenue, 52% operating profit, $3.4B cash, Epkinly, Rina-S, and Anthropic AI ...

NORTH CHICAGO, Ill., Dec. 2, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced it will unveil new data at the 2025 American Society of Hematology (ASH) Congress, showcasing continued advances ...

STOCKHOLM/LONDON, Nov 28 (Reuters) - The global boom in data centers as companies increasingly outsource information storage and ramp up use of energy-intensive artificial intelligence is creating a ...

Process manufacturers and power producers are feeling the pressure of tight margins and increasing economic uncertainty. The data tools that engineers and plant operators have relied on for years are ...

With the current state of the economy due to inflation, high-interest rates, potential AI disruptions, and a weakening labor market, it's quite refreshing to own dividend stocks. Particularly, ...

Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...

Microsoft will process M365 Copilot prompts and responses locally in 15 countries as part of its growing commitment to digital sovereignty. Microsoft will allow customers in 15 countries to process ...

As artificial intelligence drives the need for vastly more computing storage and processing power, interest in space-based data centers has spiked. Although several startup companies, such as ...

AUSTIN, Texas, Oct. 28, 2025 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients ...

In patients with previously untreated diffuse large B-cell lymphoma (DLBCL), polatuzumab vedotin, rituximab, cyclophosphamide, doxorubicin, and prednisone (Pola-R-CHP) demonstrated sustained ...